Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

RecruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2030

Study Completion Date

July 31, 2032

Conditions
SepsisSystemic Inflammatory Response SyndromeInfection MixedInfection, BacterialInfection, FungalInfection, Coronavirus
Interventions
DEVICE

Gene Z or other rapid diagnostic techniques developed in our lab (as of 2018 not using Gene Z - now using In-Dx along with other developed techniquesregularly)

The Gene Z device (no longer in use) and now using In-Dx created in our lab, and other rapid diagnostic techniques that we have developed in our lab will be used to analyze previously processed specimens for microbial organisms and compared to prior culture and sensitivity results. It is not a separate arm - all samples will be cultured in lab per standard protocol and then the Gene Z device or other rapid diagnostic techniques developed in our lab will be used to re-analyze at a later date specimens that were previously frozen and stored and compared to culture results

Trial Locations (2)

48909

RECRUITING

University of Michigan Health/Sparrow (name change only), Lansing

48910

RECRUITING

McLaren Greater Lansing, Lansing

All Listed Sponsors
lead

Michigan State University

OTHER